Finanzwire Finanzwire
Basculer en Français
11166 Companies
246602 Keywords
174550 Articles
133184 Press releases
Headlines Articles Press releases EspeRare Foundation Remove
  1. Home
  2. Companies
  3. EspeRare Foundation
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/13/2026 at 15:20, 8 months 30 days ago

    N-Lorem and EspeRare Collaborate to Enhance Access to ASO Therapies in Europe

    EspeRare N-Lorem ASO Therapies Rare Genetic Diseases European Collaboration
  • PRESS RELEASE

    published on 01/13/2026 at 15:15, 8 months 30 days ago

    n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

    n-Lorem and EspeRare collaborate to expand access to individualized ASO Therapies for Rare Genetic Diseases in Europe, focusing on Switzerland and EU, to develop regulatory and clinical pathways
    EspeRare N-Lorem ASO Therapies Rare Genetic Diseases European Collaboration
    Logo of EspeRare Foundation
  • BRIEF

    published on 12/03/2025 at 18:45, 10 months 9 days ago

    EspeRare Secures Gates Foundation Grant for Preeclampsia Therapy

    Therapy Development Maternal Health Gates Foundation Preeclampsia EspeRare
  • PRESS RELEASE

    published on 12/03/2025 at 18:40, 10 months 9 days ago

    EspeRare receives a grant from the Gates Foundation to advance a novel therapy for preeclampsia

    EspeRare receives a grant from the Gates Foundation to advance a novel therapy for preeclampsia. The grant supports their mission to bring life-changing therapies to under-resourced settings worldwide
    Grant Gates Foundation Preeclampsia EspeRare Therapy
    Logo of EspeRare Foundation
Accesswire
  • Published on 10/13/2026 at 15:00, 15 minutes ago

    Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend

  • Published on 10/13/2026 at 14:45, 30 minutes ago

    Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

  • Published on 10/13/2026 at 14:31, 44 minutes ago

    First Breach Completes First Autonomous Flight of Proprietary Drone Prototype

  • Published on 10/13/2026 at 14:10, 1 hour 5 minutes ago

    NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements

  • Published on 10/13/2026 at 14:00, 1 hour 15 minutes ago

    Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

View all ACCESSWIRE
EQS Group
  • Published on 10/13/2026 at 15:06, 8 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 10/13/2026 at 15:05, 9 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

  • Published on 10/13/2026 at 15:05, 9 minutes ago

    Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats

  • Published on 10/13/2026 at 15:03, 11 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

  • Published on 10/13/2026 at 15:02, 12 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

View all EQS
Les Echos
  • Published on 10/13/2026 at 09:04, 6 hours 10 minutes ago

    Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards

  • Published on 10/12/2026 at 17:59, 21 hours 15 minutes ago

    Reporting on share buyback transactions carried out between October 7 and October 9, 2026

  • Published on 10/12/2026 at 17:45, 21 hours 30 minutes ago

    Weekly share buyback

  • Published on 10/12/2026 at 17:45, 21 hours 30 minutes ago

    Declaration of transactions on own shares from October 5, 2026 to October 11, 2026

  • Published on 10/12/2026 at 15:47, 23 hours 27 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy